SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (7338)12/21/1999 10:42:00 PM
From: scaram(o)uche  Respond to of 9719
 
those are tough to beat.......

NBIX and Gluh..... glee...... gluh......



To: Vector1 who wrote (7338)12/21/1999 11:30:00 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 9719
 
My vote is for IMNX-Enbrel.



To: Vector1 who wrote (7338)12/22/1999 7:45:00 AM
From: David Cathcart  Respond to of 9719
 
I nominate MOGN, but it has been so clandestine in its efforts that it also should be nominated for this year's Rodney Dangerfield award.

MOGN will be a better candidate next year when the MGI-114 (now irofulven) PII data is presented for for prostate and pancreatic cancers.

David